{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:54:55Z","timestamp":1763564095833,"version":"3.37.3"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12026-020-09147-3","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T02:02:54Z","timestamp":1597716174000},"page":"246-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["TNF, IL-6, and IL-10 cytokines levels and their polymorphisms in renal function and time after transplantation"],"prefix":"10.1007","volume":"68","author":[{"given":"Lorraine Vieira","family":"Alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suellen Rodrigues","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina","family":"Sim\u00f5es e Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina Neris","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina Braga","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7739-6440","authenticated-orcid":false,"given":"Ana Paula Lucas","family":"Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"9147_CR1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ckj\/sfx088","volume":"11","author":"J Jarl","year":"2018","unstructured":"Jarl J, Desatnik P, Hansson UP, Pr\u00fctz KG, Gerdtham U. Do kidney transplantations save money? A study using a before-after design and multiple register-based data from Sweden. Clin Kidney J. 2018;11:283\u20138.","journal-title":"Clin Kidney J"},{"key":"9147_CR2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5301\/jn.5000048","volume":"25","author":"C Ponticelli","year":"2012","unstructured":"Ponticelli C. The mechanisms of acute transplant rejection revisited. J Nephrol. 2012;25:150\u20138.","journal-title":"J Nephrol"},{"key":"9147_CR3","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s11255-018-1918-6","volume":"50","author":"L Gu","year":"2018","unstructured":"Gu L, Tao Y, Chen C, Ye Y, Xiong X, Sun Y. Initiation of the inflammatory response after renal ischemia\/reperfusion injury during renal transplantation. Int Urol Nephrol. 2018;50:2027\u201335.","journal-title":"Int Urol Nephrol"},{"key":"9147_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12974-016-0569-8","volume":"13","author":"L Srinivas","year":"2016","unstructured":"Srinivas L, Vellichirammal NN, Alex AM, Nair C, Nair IV, Banerjee M. Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia. J Neuroinflammation. 2016;13:105.","journal-title":"J Neuroinflammation"},{"key":"9147_CR5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.20452\/pamw.14997","volume":"129","author":"H Schmid","year":"2019","unstructured":"Schmid H, Lederer SR. Urinary biomarkers: on the long road to personalized renal transplant medicine. Pol Arch Intern Med. 2019;129:577\u20139.","journal-title":"Pol Arch Intern Med"},{"key":"9147_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ki.2014.285","volume":"87","author":"RS Al-Lamki","year":"2015","unstructured":"Al-Lamki RS, Mayadas TN. TNF receptors: signaling pathways and contribution to renal dysfunction. Kidney Int. 2015;87:281\u201396.","journal-title":"Kidney Int"},{"key":"9147_CR7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrd1175","volume":"2","author":"MA Palladino","year":"2003","unstructured":"Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov. 2003;2:736\u201346.","journal-title":"Nat Rev Drug Discov"},{"key":"9147_CR8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1600-6143.2008.02536.x","volume":"9","author":"U Hoffmann","year":"2009","unstructured":"Hoffmann U, Bergler T, Rihm M, Pace C, Kr\u00fcger B, R\u00fcmmele P, et al. Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Am J Transplant. 2009;9:675\u201386.","journal-title":"Am J Transplant"},{"key":"9147_CR9","doi-asserted-by":"crossref","first-page":"2197595","DOI":"10.1155\/2016\/2197595","volume":"2016","author":"AI S\u00e1nchez-fructuoso","year":"2016","unstructured":"S\u00e1nchez-fructuoso AI, P\u00e9rez-Flores I, Valero R, Moreno MA, Fernandez-Arquero M, Urcelay E, et al. The polymorphism \u2212308G\/A of tumor necrosis factor-\u03b1 gene modulates the effect of immunosuppressive treatment in first kidney transplant subjects who suffer an acute rejection. J Immunol Res. 2016;2016:2197595.","journal-title":"J Immunol Res"},{"key":"9147_CR10","first-page":"721","volume":"127","author":"M Akdis","year":"2011","unstructured":"Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, et al. Interleukins, from 1 to 37, and interferon-g: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127:721\u2013812.","journal-title":"J Allergy Clin Immunol"},{"key":"9147_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.immuni.2013.10.022","volume":"40","author":"CA Fielding","year":"2014","unstructured":"Fielding CA, Jones GW, McLoughlin RM, McLeod L, Hammond VJ, Uceda J, et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity. 2014;40:40\u201350.","journal-title":"Immunity"},{"key":"9147_CR12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.RES.0000115557.25127.8D","volume":"94","author":"S Wassmann","year":"2004","unstructured":"Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, B\u00f6hm M, et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res. 2004;94:534\u201341.","journal-title":"Circ Res"},{"key":"9147_CR13","first-page":"369","volume":"102","author":"D Fishman","year":"1998","unstructured":"Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL- 6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:369\u201376.","journal-title":"J Clin Invest"},{"key":"9147_CR14","first-page":"2699","volume":"8","author":"W Jia","year":"2015","unstructured":"Jia W, Fei GH, Hu JG, Hu XW. A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer. Onco Targets Ther. 2015;8:2699\u2013704.","journal-title":"Onco Targets Ther"},{"key":"9147_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","volume":"21","author":"R Sabat","year":"2010","unstructured":"Sabat R, Gr\u00fctz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331\u201344.","journal-title":"Cytokine Growth Factor Rev"},{"key":"9147_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5500\/wjt.v3.i4.91","volume":"3","author":"I Sinuani","year":"2013","unstructured":"Sinuani I, Beberashvili I, Averbukh Z, Sandbank J. Role of IL-10 in the progression of kidney disease. World J Transplant. 2013;3:91\u20138.","journal-title":"World J Transplant"},{"key":"9147_CR17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3748\/wjg.v18.i8.847","volume":"18","author":"F Liu","year":"2012","unstructured":"Liu F, Li B, Wang WT, Wei YG, Yan LN, Wen TF, et al. Interleukin-10-1082G\/A polymorphism and acute liver graft rejection: a meta-analysis. World J Gastroenterol. 2012;18:847\u201354.","journal-title":"World J Gastroenterol"},{"key":"9147_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","volume":"24","author":"DM Turner","year":"1997","unstructured":"Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1\u20138.","journal-title":"Eur J Immunogenet"},{"key":"9147_CR19","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.transproceed.2005.08.004","volume":"37","author":"A Amirzargar","year":"2005","unstructured":"Amirzargar A, Lessanpezeshki M, Fathi A, Amirzargar M, Khosravi F, Ansaripour B, et al. Th1\/Th2 cytokine analysis in Iranian renal transplant recipients. Transplant Proc. 2005;37:2985\u20137.","journal-title":"Transplant Proc"},{"key":"9147_CR20","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4103\/1319-2442.215122","volume":"28","author":"MM Elnokeety","year":"2017","unstructured":"Elnokeety MM, Shaker AM, Fayed AM. Urinary interleukin-10 in renal transplant recipients: does it predict a state of tolerance or rejection. Saudi J Kidney Dis Transpl. 2017;28:1196\u2013200.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"9147_CR21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11033-011-0765-7","volume":"39","author":"MH Karimi","year":"2012","unstructured":"Karimi MH, Daneshmandi S, Pourfathollah AA, Geramizadeh B, Yaghobi R, Rais-Jalali GA, et al. A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients. Mol Biol Rep. 2012;39:509\u201315.","journal-title":"Mol Biol Rep"},{"key":"9147_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOT.0b013e32834ef52a","volume":"17","author":"IF Ashoor","year":"2012","unstructured":"Ashoor IF, Najafian N. Rejection and regulation: a tight balance. Curr Opin Organ Transplant. 2012;17:1\u20137.","journal-title":"Curr Opin Organ Transplant"},{"key":"9147_CR23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000444267","volume":"132","author":"D Cucchiari","year":"2016","unstructured":"Cucchiari D. Podest\u00e0 Ma, Ponticelli C. the critical role of innate immunity in kidney transplantation. Nephron. 2016;132:227\u201337.","journal-title":"Nephron."},{"key":"9147_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Stevens PE, Bilous RW, Coresh J, Francisco ALM, Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"key":"9147_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/j.ackd.2017.09.013","volume":"25","author":"WG Miller","year":"2018","unstructured":"Miller WG, Jones GRD. Estimated glomerular filtration rate; laboratory implementation and current global status. Adv Chronic Kidney Dis. 2018;25:7\u201313.","journal-title":"Adv Chronic Kidney Dis"},{"key":"9147_CR26","doi-asserted-by":"crossref","first-page":"e69998","DOI":"10.1371\/journal.pone.0069998","volume":"8","author":"FB Rodrigues","year":"2013","unstructured":"Rodrigues FB, Bruetto RG, Torres US, Otaviano AP, Zanetta DM, Burdmann EA. Incidence and mortality of acute kidney injury after myocardial infarction: a comparison between KDIGO and RIFLE criteria. PLoS One. 2013;8:e69998.","journal-title":"PLoS One"},{"key":"9147_CR27","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1600-6143.2004.00662.x","volume":"4","author":"PF Halloran","year":"2004","unstructured":"Halloran PF, Langone AJ, Helderman JH, Kaplan B. Assessing long-term nephron loss: is it time to kick the CAN grading system? Am J Transplant. 2004;4:1729\u201330.","journal-title":"Am J Transplant"},{"key":"9147_CR28","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.transproceed.2011.05.055","volume":"43","author":"F Samaan","year":"2011","unstructured":"Samaan F, Requi\u00e3o-Moura LR, Pinheiro HS, Ozaki KS, C\u00e2mara NOS, Pacheco-Silva A. Prevalence and progression of chronic kidney disease after renal transplantation. Transplant Proc. 2011;43:2587\u201391.","journal-title":"Transplant Proc"},{"key":"9147_CR29","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.transproceed.2009.07.041","volume":"41","author":"GH Naderi","year":"2009","unstructured":"Naderi GH, Mehraban D, Kazemeyni SM, Darvishi M, Latif AH. Living or deceased donor kidney transplantation: a comparison of results and survival rates among Iranian patients. Transplant Proc. 2009;41:2772\u20134.","journal-title":"Transplant Proc"},{"key":"9147_CR30","first-page":"e12182","volume":"6","author":"E Nemati","year":"2014","unstructured":"Nemati E, Einollahi B, Lesan Pezeshki M, Porfarziani V, Fattahi MR. Does kidney transplantation with deceased or living donor affect graft survival? Nephrourol Mon. 2014;6:e12182.","journal-title":"Nephrourol Mon"},{"key":"9147_CR31","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/00007890-199405000-00008","volume":"57","author":"PI Terasaki","year":"1994","unstructured":"Terasaki PI, Koyama H, Cecka JM, Gjertson DW. The hyperfiltration hypothesis in human renal transplantation. Transplantation. 1994;57:1450\u20134.","journal-title":"Transplantation"},{"key":"9147_CR32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/0886022X.2015.1106770","volume":"38","author":"Q Hu","year":"2016","unstructured":"Hu Q, Tian H, Wu Q, Li J, Cheng X, Liao P. Interleukin-10-1082 G\/a polymorphism and acute renal graft rejection: a meta-analysis. Ren Fail. 2016;38:57\u201364.","journal-title":"Ren Fail"},{"key":"9147_CR33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.arcmed.2018.04.015","volume":"49","author":"V Perovic","year":"2018","unstructured":"Perovic V, Markovic M, Kravljaca M, Milosevic E, Djoric M, Pravica V, et al. Cytokine gene polymorphism profiles in kidney transplant patients - association of +1188A\/C RS3212227 SNP in the IL12B gene prevents delayed graft function. Arch Med Res. 2018;49:101\u20138.","journal-title":"Arch Med Res"},{"key":"9147_CR34","doi-asserted-by":"crossref","unstructured":"Rashad RH, Mahmoud KM, Hady TMAA, El-Agroudy AEB, Hamdy AF, Ismail AM, et al. IL-10 gene polymorphism and graft outcome in live- donor kidney transplantation. J Egypt Soc Nephrol Transplant. 2016, 2016;16:89\u201396.","DOI":"10.4103\/1110-9165.197381"},{"key":"9147_CR35","doi-asserted-by":"crossref","first-page":"e0127540","DOI":"10.1371\/journal.pone.0127540","volume":"10","author":"J Xiong","year":"2015","unstructured":"Xiong J, Wang Y, Zhang Y, Nie L, Wang D, Huang Y, et al. Lack of association between interleukin-10 gene polymorphisms and graft rejection risk in kidney transplantation recipients: a meta-analysis. PLoS One. 2015;10:e0127540.","journal-title":"PLoS One"},{"key":"9147_CR36","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/TP.0b013e3181ea391e","volume":"90","author":"F Khan","year":"2010","unstructured":"Khan F, Sar A, Gonul I, Benediktsson H, Doulla J, Yilmaz S, et al. Graft inflammation and histologic indicators of kidney chronic allograft failure: low-expressing interleukin-10 genotypes cannot be ignored. Transplantation. 2010;90:630\u20138.","journal-title":"Transplantation"},{"key":"9147_CR37","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1093\/ndt\/gfn185","volume":"23","author":"A Thakkinstian","year":"2008","unstructured":"Thakkinstian A, Dmitrienko S, Gerbase-Delima M, McDaniel DO, Inigo P, Chowet KM, et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data. Nephrol Dial Transplant. 2008;23:3017\u201323.","journal-title":"Nephrol Dial Transplant"},{"key":"9147_CR38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.12659\/AOT.883931","volume":"18","author":"G La Manna","year":"2013","unstructured":"La Manna G, Cappuccilli ML, Capelli I, Baraldi O, Cuna V, Battaglino G, et al. The impact of apoptosis and inflammation gene polymorphisms on transplanted kidney function. Ann Transplant. 2013;18:256\u201364.","journal-title":"Ann Transplant"},{"key":"9147_CR39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1399-0039.2010.01623.x","volume":"77","author":"M Kocierz","year":"2011","unstructured":"Kocierz M, Siekiera U, Kolonko A, Karkoszka H, Chudek J, Cierpka L, et al. 174G\/C interleukin-6 gene polymorphism and the risk of transplanted kidney failure or graft loss during a 5-year follow-up period. Tissue Antigens. 2011;77:283\u201390.","journal-title":"Tissue Antigens"},{"key":"9147_CR40","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1167\/iovs.16-21400","volume":"58","author":"M Arbab","year":"2017","unstructured":"Arbab M, Tahir S, Niazi MK, Ishaq M, Hussain A, Siddique PM, et al. TNF-\u03b1 genetic predisposition and higher expression of inflammatory pathway components in keratoconus. Invest Ophthalmol Vis Sci. 2017;58:3481\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9147_CR41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.trim.2006.09.001","volume":"16","author":"K Gendzekhadze","year":"2006","unstructured":"Gendzekhadze K, Rivas-Vetencourt P, Montano RF. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha \u2212308 single nucleotide polymorphisms: a preliminary study. Transpl Immunol. 2006;16:194\u20139.","journal-title":"Transpl Immunol"},{"key":"9147_CR42","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.transproceed.2012.12.006","volume":"45","author":"T Dhaouadi","year":"2013","unstructured":"Dhaouadi T, Sfar I, Bardi R, Jendoubi-Ayed S, Abdallah TB, Ayed K, et al. Cytokine gene polymorphisms in kidney transplantation. Transplant Proc. 2013;45:2152\u20137.","journal-title":"Transplant Proc"},{"key":"9147_CR43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2567.2008.02933.x","volume":"127","author":"S Masli","year":"2009","unstructured":"Masli S, Turpie B. Anti-inflammatory effects of tumour necrosis factor (TNF)-alpha are mediated via TNF-R2 (p75) in tolerogenic transforming growth factor-beta-treated antigen-presenting cells. Immunology. 2009;127:62\u201372.","journal-title":"Immunology"},{"key":"9147_CR44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1359-6101(01)00020-X","volume":"13","author":"F Balkwill","year":"2002","unstructured":"Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13:135\u201341.","journal-title":"Cytokine Growth Factor Rev"},{"key":"9147_CR45","doi-asserted-by":"crossref","first-page":"12708","DOI":"10.1038\/s41598-017-12703-x","volume":"7","author":"C Agnoli","year":"2017","unstructured":"Agnoli C, Grioni S, Pala V, Allione A, Matullo G, Gaetano CD, et al. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort. Sci Rep. 2017;7:12708.","journal-title":"Sci Rep"},{"key":"9147_CR46","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4049\/jimmunol.1000560","volume":"185","author":"FS Kleijwegt","year":"2010","unstructured":"Kleijwegt FS, Laban S, Duinkerken G, Joosten AM, Zaldumbide A, Nikolic T, et al. Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells. J Immunol. 2010;185:1412\u20138.","journal-title":"J Immunol"},{"key":"9147_CR47","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fimmu.2018.00444","volume":"9","author":"BL Salomon","year":"2018","unstructured":"Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E, Cohen JL. Tumor necrosis factor \u03b1 and regulatory T cells in Oncoimmunology. Front Immunol. 2018;9:444.","journal-title":"Front Immunol"},{"key":"9147_CR48","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/blood-2016-04-711275","volume":"128","author":"A Pierini","year":"2016","unstructured":"Pierini A, Strober W, Moffett C, Baker J, Nishikii H, Alvarez M, et al. TNF-\u03b1 priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment. Blood. 2016;128:866\u201371.","journal-title":"Blood"},{"key":"9147_CR49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/2251-6581-13-46","volume":"13","author":"JT Bazzaz","year":"2014","unstructured":"Bazzaz JT, Amoli MM, Taheri Z, Larijani B, Pravica V, Hutchinson IV. TNF-alpha and IFN-gamma gene variation and genetic susceptibility to type 1 diabetes and its microangiopathic complications. J Diabetes Metab Disord. 2014;13:46.","journal-title":"J Diabetes Metab Disord"},{"key":"9147_CR50","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ni.3399","volume":"17","author":"M Beyer","year":"2016","unstructured":"Beyer M, Abdullah Z, Chemnitz JM, Maisel D, Sander J, Lehmann C, et al. Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infection. Nat Immunol. 2016;17:593\u2013603.","journal-title":"Nat Immunol"},{"key":"9147_CR51","doi-asserted-by":"crossref","first-page":"13644","DOI":"10.1073\/pnas.0803429105","volume":"105","author":"L Ban","year":"2008","unstructured":"Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D, Faustman DL. Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism. Proc Natl Acad Sci U S A. 2008;105:13644\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9147_CR52","first-page":"819","volume":"67","author":"M Kotowski","year":"2016","unstructured":"Kotowski M, Bogacz A, Bartkowiak-wieczorek J, Sienko J, Procyk D, Dziewanowski K, et al. The influence of the tumor necrosis factor-alpa-308G>A polymorphism on the efficacy of immunosuppressive therapy in patients after kidney transplantation. J Physiol Pharmacol. 2016;67:819\u201326.","journal-title":"J Physiol Pharmacol"},{"key":"9147_CR53","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/nep.13114","volume":"23","author":"APL Mota","year":"2017","unstructured":"Mota APL, Menezes CA, Alpoim PN, Cardoso CN, Martins SR, Alves LV, et al. Regulatory and pro-inflammatory cytokines in brazilian living-related renal transplant recipients according to creatinine plasma levels. Nephrology (Carlton). 2017;23:867\u201375.","journal-title":"Nephrology (Carlton)"},{"key":"9147_CR54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5935\/1676-2444.20150049","volume":"51","author":"LV Alves","year":"2015","unstructured":"Alves LV, Maia MJO, Nunes FFC, Magalh\u00e3es HPB, Afonso DAF, Mota APL. Creatinine and cytokines plasma levels related to HLA compatibility in kidney transplant patients. J Bras Patol Med Lab. 2015;51:303\u20139.","journal-title":"J Bras Patol Med Lab"},{"key":"9147_CR55","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1172\/JCI39933","volume":"120","author":"KA Newell","year":"2010","unstructured":"Newell KA. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest. 2010;120:1836\u201347.","journal-title":"J Clin Invest"},{"key":"9147_CR56","doi-asserted-by":"crossref","first-page":"20044","DOI":"10.1038\/srep20044","volume":"6","author":"E Nova-Lamperti","year":"2016","unstructured":"Nova-Lamperti E, Fanelli G, Becker PD, Chana P, Elgueta R, Dodd PC, et al. IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses. Sci Rep. 2016;6:20044.","journal-title":"Sci Rep"},{"key":"9147_CR57","doi-asserted-by":"crossref","unstructured":"Ma L, Zhang H, Hu K, Lv G, Fu Y, Ayana DA, Zhao P, Jiang Y Desalegn Admassu Ayana. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients. BMC Immunol 2015;16:56.","DOI":"10.1186\/s12865-015-0118-8"},{"key":"9147_CR58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2164-9-71","volume":"9","author":"B Edemir","year":"2008","unstructured":"Edemir B, Kurian SM, Eisenacher M, Lang D, M\u00fcller-Tidow C, Gabri\u00ebls G, et al. Activation of counter-regulatory mechanisms in a rat renal acute rejection model. BMC Genomics. 2008;9:71.","journal-title":"BMC Genomics"},{"key":"9147_CR59","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.transproceed.2013.02.109","volume":"45","author":"O Mazanowska","year":"2013","unstructured":"Mazanowska O, Kami\u0144ska D, Krajewska M, Banasik M, Zabi\u0144ska M, Ko\u015bcielska-Kasprzak K, et al. Increased plasma tissue inhibitors of metalloproteinase concentrations as negative predictors associated with deterioration of kidney allograft function upon long-term observation. Transplant Proc. 2013;45:1458\u201361.","journal-title":"Transplant Proc"},{"issue":"3","key":"9147_CR60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cyto.2011.12.006","volume":"57","author":"SW Reinhold","year":"2012","unstructured":"Reinhold SW, Straub RH, Kr\u00fcger B, Kaess B, Bergler T, Weingart C, et al. Elevated urinary sVCAM-1, IL6, sIL6R and TNFR1 concentrations indicate acute kidney transplant rejection in the first 2 weeks after transplantation. Cytokine. 2012;57(3):379\u201388.","journal-title":"Cytokine."},{"key":"9147_CR61","first-page":"1024","volume":"33","author":"Z Jin","year":"2017","unstructured":"Jin Z, Xu C, Duan W, Yang J, Tian P. The level of IL-2 and IL-6 in stimulated peripheral lymphocyte supernatants of kidney transplant recipients can predict acute renal allograft rejection. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:1024\u20139.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"9147_CR62","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.febslet.2011.04.025","volume":"585","author":"X Chen","year":"2011","unstructured":"Chen X, Oppenheim JJ. Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity. FEBS Lett. 2011;585:3611\u20138.","journal-title":"FEBS Lett"},{"key":"9147_CR63","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/0886022X.2015.1015425","volume":"37","author":"D Budak","year":"2015","unstructured":"Budak D, Yilmaz VT, Akbas H, Suleymanlar G, Yucel G. Association between graft function and serum TNF-\u03b1, TNFR1 and TNFR2 levels in patients with kidney transplantation. Ren Fail. 2015;37:871\u20136.","journal-title":"Ren Fail"},{"key":"9147_CR64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1590\/S0104-42302011000300020","volume":"57","author":"JR Lima","year":"2011","unstructured":"Lima JR, Salgado JV, Ferreira TC, Oliveira MI, Santos AM, Salgado Filho N. Cystatin C and inflammatory markers in kidney transplant recipients. Rev Assoc Med Bras (1992). 2011;57:347\u201352.","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"9147_CR65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4174\/jkss.2012.83.2.69","volume":"83","author":"YJ Jung","year":"2012","unstructured":"Jung YJ, Lee HR, Kwon OJ. Comparison of serum cystatin C and creatinine as a marker for early detection of decreasing glomerular filtration rate in renal transplants. J Korean Surg Soc. 2012;83:69\u201374.","journal-title":"J Korean Surg Soc"},{"key":"9147_CR66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12882-018-1065-4","volume":"19","author":"M Matsunami","year":"2018","unstructured":"Matsunami M, Ubara Y, Sumida K, Oshima Y, Oguro M, Kinoshita K, et al. The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome. BMC Nephrol. 2018;19:263.","journal-title":"BMC Nephrol"},{"key":"9147_CR67","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/01.TP.0000157773.96534.29","volume":"79","author":"EM Simmons","year":"2005","unstructured":"Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation. 2005;79:914\u20139.","journal-title":"Transplantation"},{"key":"9147_CR68","doi-asserted-by":"crossref","first-page":"42791","DOI":"10.1038\/srep42791","volume":"7","author":"B Kessler","year":"2017","unstructured":"Kessler B, Rinchai D, Kewcharoenwong C, Nithichanon A, Biggart R, Hawrylowicz CM, et al. Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei. Sci Rep. 2017;7:42791.","journal-title":"Sci Rep"},{"key":"9147_CR69","first-page":"47","volume-title":"Frontiers in Transplantology","author":"L Boucault","year":"2016","unstructured":"Boucault L, B\u00e9zie S, Ossart J, Guillonneau C. Tolerance in organ transplantation. In: Abdeldayem H, El-Kased AF, El-Shaarawy A, editors. Frontiers in Transplantology. 1rd ed. IntechOpen: Croatia; 2016. p. 47\u201387.","edition":"1"},{"key":"9147_CR70","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5414\/CNP73333","volume":"73","author":"JE Cooper","year":"2010","unstructured":"Cooper JE, Wiseman AC. Novel immunosuppressive agents in kidney transplantation. Clin Nephrol. 2010;73:333\u201343.","journal-title":"Clin Nephrol"},{"key":"9147_CR71","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/eji.200939688","volume":"39","author":"S Sakaguchi","year":"2009","unstructured":"Sakaguchi S, Wing K, Yamaguchi T. Dynamics of peripheral tolerance and immune regulation mediated by Treg. Eur J Immunol. 2009;39:2331\u20136.","journal-title":"Eur J Immunol"},{"key":"9147_CR72","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cyto.2013.03.001","volume":"62","author":"AP Mota","year":"2013","unstructured":"Mota AP, Vila\u00e7a SS, das Merc\u00eas FL Jr, Pinheiro Mde B, Teixeira-Carvalho A, Silveira AC, et al. Cytokines signatures in short and long-term stable renal transplanted patients. Cytokine. 2013;62:302\u20139.","journal-title":"Cytokine"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09147-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-020-09147-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-020-09147-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:13:21Z","timestamp":1629245601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-020-09147-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["9147"],"URL":"https:\/\/doi.org\/10.1007\/s12026-020-09147-3","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"type":"print","value":"0257-277X"},{"type":"electronic","value":"1559-0755"}],"subject":[],"published":{"date-parts":[[2020,8,18]]},"assertion":[{"value":"18 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}